These data are interesting in light of the lower frequency of MES (or analogous MITF-low/AXL-high) samples across many published melanoma cell line and patient tumor cohorts1,64, indicating that the higher prevalence of the MEL state in cell line panels is unlikely to be explained solely by a selective advantage to sustained in vitro culture. This evidence concerns the gene MITF and melanoma.